Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




ACR Expands Pilot Program Focused on AI and Radiology

By HospiMedica International staff writers
Posted on 06 Jul 2019
Radiology professionals from seven renowned health care institutions will use the ACR AI-LAB to demonstrate the process of creating investigational artificial intelligence (AI) models from image data without the use of a programming language. More...
Using an AI model developed at one institution, each of the seven institutions will have the ability to evaluate and optimize the model for their own investigational use.

The American College of Radiology {(ACR), Reston, VA, USA} is making available the ACR AI-LAB as a service, which provides a vendor-neutral framework to facilitate the development, modeling and validation of AI tools. Based on the recently announced ACR AI-LAB reference architecture, this pilot represents a major milestone in the effort to allow institutions to develop high-quality algorithms that address local clinical needs, some of which may ultimately be made commercially available. In addition to the seven institutions, there are two major technology contributors; NVIDIA is providing software and edge infrastructure, and Nuance is providing last-mile integration to the participating radiologist.

The pilot – originally including Massachusetts General Hospital and The Ohio State University – now also includes Lahey Hospital and Medical Center, Emory University, The University of Washington, the University of California San Francisco and Brigham and Women’s Hospital. NVIDIA will provide its NVIDIA Clara AI software toolkits at no cost to the institutions to perform the annotation creation, transfer learning, and pipeline integration. In addition, Nuance will provide the last-mile technology required to integrate AI for the participating radiologist. Once the pilot is complete, the initiative is anticipated to progressively expand to all institutions interested in participating.

Sharing local AI models from image data between institutions for fine tuning — while patient information remains securely on site at the originating institution — has not previously been done successfully in radiology at this scale. This is due, in part, to the variability in how medical images are created, including the equipment, software, and protocols used. The pilot sites will use ACR AI-LAB to evaluate AI developed elsewhere, modifying the investigational algorithms to improve performance based on testing and evaluating them on local patient data. Creating the local AI models will not require ACR AI-LAB users to have programming skills. ACR AI-LAB allows users to adjust and change AI models without having to make line-by-line changes to the underlying code.

Once the pilot is complete, the consortium is anticipated to progressively expand to more institutions and vendors interested in participating. The investigational algorithms resulting from this project will undergo further evaluation and refinement by sites should they pursue commercialization, including obtaining appropriate regulatory clearance or approvals, as applicable.

“Today marks a major step in accelerating the development of AI for medical imaging. We know algorithms can underperform when deployed at sites where they weren’t trained. Now, radiologists in the pilot program will have access to AI algorithms developed outside their institutions in order evaluate a model’s performance using their own data and, as necessary, retrain the algorithm using their local data to enhance its performance,” said Bibb Allen Jr., MD, FACR, ACR Data Science Institute (ACR DSI) Chief Medical Officer.

“AI technology is entering the next phase where software writes software and less computer science expertise is required,” said Abdul Hamid Halabi, director of healthcare, at NVIDIA. “Radiologists have always been technology trailblazers. Working with the ACR AI-LAB to bring NVIDIA’s AI computing capability to the edge — where radiologists and their data reside — we are demonstrating that investigational AI tools can be made available to any imaging institution.”

Related Links:
American College of Radiology


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.